Daiichi Sankyo raises profit outlook as Ranbaxy drives growth
This article was originally published in Scrip
Executive Summary
Daiichi Sankyo has raised it net profit forecast for the current fiscal year by ¥5.0 billion to ¥45.0 billion ($497.8 million), on the back of expected non-operating gains on the valuation of Ranbaxy's foreign exchange derivatives.